Gilead Sciences (GILD) has an interesting forecast.
What’s up with Gilead Sciences?
Gilead Sciences (GILD) opened at $85.47, which means the stock is up 1.03% from yesterday’s closing price of 83.14. Today, the company has a high of $85.67 and a low of $81.33. The company has a market cap of $105.758 billion with a 52-week high of $85.97 and a 52-week low of $60.89.
What about the future for Gilead Sciences
The high forecast for Gilead Sciences is 90.00 while the low is 58.00. Stock forecasts are based on human experience: Human traders based on their experience in terms of stock price patterns, volume changes, and market news/rumors regarding a particular stock. Gilead Sciences has a weak forecast. A weak forecast is due to the company posting consistent losses in their earning reports. The future outlook does not seem too bright as this could potentially cause the company to file for bankruptcy.. Based on this information GILD seems to be a risky buy.
About Gilead Sciences
Gilead Sciences, Inc., is an American biopharmaceutical company that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi